Linda Allais is Director of Scientific Operations at Charles River, Lyon (France) and has 23 years' experience in non-clinical Safety Assessment (Pharma and CROs). Linda started her carrier in the development of alternative methods for the optimization of lead candidate selection. She then worked as Toxicologist/Study Director in Genetic, General, Reproductive, Developmental and Juvenile Toxicology studies. After being a Program Manager and Scientific Advisor, Linda used her expertise to advise Clients on drug development plans, including FIH-, Phase 2-, Phase 3- and pediatric- enabling packages. With emerging small/virtual biotech companies, Linda also had the opportunity to help in the selection of intended dose, route and duration of treatment in clinics and in the preparation of the nonclinical sections for regulatory submissions. Linda is author and co-author of at least 10 scientific publications. Linda is European Registered Toxicologist and has recently obtained a PhD in Paris-Saclay University in Developmental Immunotoxicology in Juvenile Minipigs.
Director, Scientific Operations